Roth Capital Expects Increased Earnings for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Roth Capital increased their Q2 2025 earnings estimates for shares of Core Scientific in a report released on Thursday, May 8th. Roth Capital analyst D. Aftahi now expects that the company will post earnings of ($0.11) per share for the quarter, up from their previous estimate of ($0.12). The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific's Q4 2025 earnings at ($0.07) EPS and FY2025 earnings at ($0.40) EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02. The firm had revenue of $79.53 million for the quarter, compared to the consensus estimate of $92.04 million. During the same period last year, the company posted $0.78 EPS. The business's revenue was down 55.6% on a year-over-year basis.

A number of other analysts also recently weighed in on CORZ. Canaccord Genuity Group reiterated a "buy" rating and set a $17.00 price target on shares of Core Scientific in a report on Friday, May 9th. HC Wainwright reiterated a "buy" rating and set a $17.00 price objective on shares of Core Scientific in a report on Tuesday, March 11th. Craig Hallum assumed coverage on Core Scientific in a report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target on the stock. Oppenheimer started coverage on Core Scientific in a report on Wednesday. They issued an "outperform" rating and a $15.00 price target on the stock. Finally, Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 target price for the company. Sixteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $18.81.

Core Scientific Price Performance

CORZ stock traded up $0.08 during trading on Monday, reaching $10.32. 13,713,477 shares of the company were exchanged, compared to its average volume of 13,037,133. The company has a 50-day moving average of $7.98 and a two-hundred day moving average of $12.03. The company has a market capitalization of $3.07 billion, a price-to-earnings ratio of -1.91 and a beta of 6.66. Core Scientific has a twelve month low of $3.46 and a twelve month high of $18.63.

Insider Buying and Selling at Core Scientific

In other news, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the completion of the sale, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. The trade was a 40.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jordan Levy purchased 62,500 shares of Core Scientific stock in a transaction dated Thursday, March 6th. The stock was bought at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now directly owns 306,887 shares of the company's stock, valued at approximately $2,458,164.87. This trade represents a 25.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Core Scientific

A number of institutional investors and hedge funds have recently bought and sold shares of CORZ. Wellington Shields & Co. LLC bought a new stake in Core Scientific in the 4th quarter valued at $26,000. First Horizon Advisors Inc. purchased a new stake in shares of Core Scientific in the fourth quarter worth about $34,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of Core Scientific in the fourth quarter worth about $42,000. Vestcor Inc purchased a new stake in shares of Core Scientific in the fourth quarter worth about $66,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in shares of Core Scientific in the first quarter worth about $38,000.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.